SecBot SecBot
SC 13G/A ·Filed Nov 13, 2026

FBRX

Forte Biosciences, Inc.
BEARISH
Impact 5/10
Horizonweeks Processed3d 9h ago SEC0001011438-26-000693
Passive stake amendment
Actionable Insight ▼ Bearish

Three passive institutional investors have now fully exited FBRX within weeks. Monitor for additional institutional selling and any potential conversion of remaining 13G filers to 13D activist filings.

DirectionBearish
Confidencehigh
Horizonweeks

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Affinity Asset Advisors, LLC filed an amendment to Schedule 13G reporting a complete exit from Forte Biosciences, reducing its beneficial ownership to 0 shares (0.00%) as of September 30, 2026. This follows similar full exits by MPM BioImpact and Tybourne Capital Management in recent weeks, showing a pattern of passive institutional liquidation.

Key Financial Metrics

Stake
0%
Stake Value
$0.00
Investor
Affinity Asset Advisors, LLC
Investor Type
hedge fund

Key Facts

  • Affinity Asset Advisors reduced its stake to 0 shares as of September 30, 2026
  • Affinity now owns 0.0% of Forte Biosciences common stock
  • This is the third passive institutional exit from FBRX in recent weeks, following MPM BioImpact and Tybourne Capital Management
  • Filing is an amendment to Schedule 13G, indicating passive investor status

Financial Impact

Complete exit by Affinity Asset Advisors; prior stake size not disclosed in this filing

institutional ownership

Risk Factors

  • Pattern of institutional exits may signal deteriorating fundamentals or loss of confidence
  • Remaining passive holders may also reduce or exit positions

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
55% bullish (11 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G/A Filing (Primary)0001011438-26-000693
Document: 0001011438-26-000693-index.html0001011438-26-000693
Document: 0001011438-26-000693.txt0001011438-26-000693

Track record

15 reports on FBRX

Performance horizon

2 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +39.79% at T+60 after the Apr 8, 2026 report. 4 of 7 went positive at some point.

Filters
  1. Nov 13, 20263d ago SC 13G/A Bearish 5/10 Viewing Entry price pending
  2. Nov 13, 20263d ago SC 13G/A Bearish 5/10 Entry price pending
  3. Nov 4, 202612d ago SC 13G/A Bearish 4/10 No price data
  4. Sep 2, 202610w ago EFFECT Bearish 7/10 Entry $76.99 settles Nov 27
  5. Sep 2, 202610w ago EFFECT Bearish 6/10 Entry $76.99 settles Nov 27
  6. Aug 27, 202611w ago 25-NSE Bearish 9/10 Entry $76.99 settles Nov 20
  7. Jul 27, 202616w ago 8-K Bullish 8/10 Entry $76.50 No price data
  8. Jun 11, 202622w ago EFFECT Bearish 6/10 Entry $17.40 No price data
  9. Jun 5, 202623w ago S-3/A Bearish 6/10 Entry $15.67 No price data
  10. Jun 2, 202623w ago S-3 Bearish 6/10 Entry $17.00 to $76.99 ▼ −352.88% −350.38% vs SPY
Showing 10 of 15

US Market Status

Market Closed · Opens in 7h 48m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 13, 2026